Transaction #20139 · Form 4 · 0001866284-25-000002
ORAGENICS INC · Stock award · Employee Stock Option (right to buy)
ORAGENICS INC · Transacted December 11, 2025 · Filed December 15, 2025
What does this filing report?
An SEC Form 4 filing for ORAGENICS INC records a stock award involving Employee Stock Option (right to buy) on December 11, 2025. The reported quantity was 250,000. The filing date is December 15, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- ORAGENICS INC
- Company CIK
- 0001174940
- Security type
- Derivative
- Acquisition type
- Stock award · Code A
- Quantity acquired
- 250,000
- Reported price
- 0
- Reference value
- 0
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 250,000
- Ownership description
- Not reported
- SEC acceptance time
- Dec 15, 2025, 4:55 PM EST
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Huffman Janet ↗
CEO and CFO
CIK 0001866284
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
This transaction is not mapped to a specific company listing.
Derivative terms
- Underlying security
- Common Stock
- Underlying quantity
- 250,000
- Conversion / exercise price
- 0.93
- Exercise date
- Not reported
- Expiration date
- December 11, 2035
Filing footnotes & remarks
- F1
- Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended. One third of the options vest on the first anniversary of the grant date and the remainder of the options subsequently vest in equal annual installments over the second and third anniversary of the grant date upon the continued performance of services by the Reporting Person to the Company through the vesting dates. The option exercise price is the Company's closing price on the date of grant.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.